OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
21 hedge funds and large institutions have $5.17M invested in Ocera Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$342K | |
| 2 | +$45K | |
| 3 | +$16K | |
| 4 |
AWS
AJ Wealth Strategies
New York
|
+$12K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$167 |
Top Sellers
| 1 | -$844K | |
| 2 | -$140K | |
| 3 | -$64.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$43.1K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$38.5K |
